OncoLink at ASCO 2001: Sunday, May 13

James Metz, MD at Poster Presentation
James Metz, MD, OncoLink Editor-in-Chief, presents Utilization of the Internet by Oncology Patients to Obtain Cancer-Related Information.

A Multicenter, Randomized, Double Blind, Placebo (PB) Controlled Trial of Marimastat (MT) In Patients with Glioblastoma Multiforme (GBM) or Gliosarcoma (GS) Following Completion of Conventional, First-Line Treatment A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study Of Novel Erythropoiesis Stimulating Protein (NESP) In Patients Undergoing Platinum Treatment For Lung Cancer A phase I and Pharmacologic trial of weekly epothilone B in patients with advanced malignancies A Phase I study of oxaliplatin in cancer patients with impaired renal function A Phase III Study Of Concomitant Oral Pilocarpine To Reduce Hypo-Salivation And Mucositis Assocated With Curative Radiation Therapy (RT) In Head And Neck (H&N) Cancer Patients. RTOG 9709 Accelerated chemoradiation to 70.6 gy is more effective than accelerated radiation to 77.6 gy alone — two year's results of a German multicenter randomized trial (ARO 95-6) Clinical pharmacology of paclitaxel in relation of patient age: CALGB 9762 Efficacy And Safety Of The Anti-Epidermal Growth Factor Antibody (EGFR) IMC-C225, In Combination With Cisplatin In Patients With Recurrent Squamous Cell Carcinoma Of The Head And Neck (SCCHN) Refractory To Cisplatin Containing Chemotherapy Maximizing Local Control And Organ Preservation In Advanced Squamous Cell Head And Neck Cancer (SCHNC) With Hyperfractionated Radiation (HRT) And Concurrent Chemotherapy Nutrition and Cancer: An Update Phase I evaluation of an epothilone B analog (BMS-247550): clinical findings and molecular correlates Phase III Study Comparing Cisplatin (C) & 5-Flurouracil (F) Versus Cisplatin & Paclitaxel (T) In Metastatic/Recurrent Head & Neck Cancer (MHNC) Phase III Trial of BCNU Plus Cisplatin (CDDP) Versus BCNU Alone, and Standard Radiation Therapy (SRT) Versus Accelerated Radiation Therapy (ART) in Glioblastoma (GBM) Patients: NCCTG/SWOG Results Predicting Risk Of Neutropenic Complications: A Point-Of-Care Assessment Tool Preliminary results of RTOG 9703 - a phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced Squamous Cell Carcinomas (SCC) of the head and neck Primary Chemotherapy (PCT) For Patients With Operable Oral Cavity Cancer: Results Of A Randomized Study Role of body-surface area in Cisplatin pharmacokinetics Role of body-surface area in Cisplatin pharmacokinetics The Shape of Things to Come: Sunday Afternoon Special Session Focuses on the Biology of Cancer


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits

Jun 2, 2015

Second study suggests new immunotherapy may benefit patients with glioblastoma

ASCO: Lymph Node Sx Doesn't Benefit All Melanoma Patients

Jun 2, 2015

Second study supports new immunotherapy for enhanced survival in advanced melanoma

2001 to 2006 Saw Increase in Mohs Surgery for Skin Cancer

Apr 18, 2012

For Medicare beneficiaries, rate of micrographic surgery for nonmelanoma skin cancer doubled